DR. DIPANJAN CHOWDHURY RECEIVES ADDITIONAL FUNDING FROM A GENEROUS DANA-FARBER DONOR
A donor has gifted $5 million to the Division of Gynecologic Oncology in the Susan F. Smith Center for Women’s Cancers at Dana-Farber Cancer Institute in recognition of the strength of the program.
“There is an urgent need for a way to diagnose ovarian cancer early, when it is most treatable, so part of this gift is supporting Dipanjan Chowdhury, PhD, chief of the Division of Radiation and Genome Stability, in developing a new blood test. This test is based on discoveries by Chowdhury, showing that gene expression regulators called microRNAs produce an ovarian cancer-specific signature detectable in blood samples.”
Click here to read the full Impact newsletter article from Dana-Farber.
Tina’s Wish researcher, Dipanjan Chowdhury, PhD, is the chief of the Division of Radiation and Genome Stability at Dana-Farber Cancer Institute: LEARN MORE ABOUT HIS RESEARCH HERE